Kidomef Oral Suspension Mango contains a combination of Mefenamic Acid (50 mg) and Paracetamol (125 mg) per 5 ml, formulated for the effective management of mild to moderate pain and fever in pediatric patients. Mefenamic Acid is a nonsteroidal anti-inflammatory drug (NSAID) that exerts analgesic, anti-inflammatory, and antipyretic effects by inhibiting cyclooxygenase enzymes, thereby reducing prostaglandin synthesis. Paracetamol, also known as acetaminophen, provides analgesic and antipyretic properties through central inhibition of prostaglandin synthesis, complementing the action of mefenamic acid. This synergistic combination offers rapid and sustained relief from conditions such as dental pain, musculoskeletal discomfort, postoperative pain, and febrile episodes associated with infections. The mango-flavored oral suspension is designed for ease of administration and improved palatability in children. Dosage should be determined based on the patient’s weight and clinical condition, adhering strictly to recommended guidelines to minimize the risk of adverse effects. Common side effects may include gastrointestinal disturbances, hypersensitivity reactions, or, rarely, hepatic or renal impairment. Kidomef Oral Suspension Mango should be used with caution in patients with a history of hypersensitivity to NSAIDs or paracetamol, and it is contraindicated in severe hepatic or renal dysfunction. Consultation with a healthcare professional is advised prior to use.